Related Experiment Video
Updated: Jun 12, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Subacute sclerosing panencephalitis: an update
Jose Gutierrez1, Richard S Issacson, Barbara S Koppel
1Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. drjosegc@hotmail.com
Subacute sclerosing panencephalitis (SSPE) is a rare, fatal neurological condition following measles infection. It disproportionately affects unvaccinated populations, leading to progressive disability and death within five years for most patients.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Subacute sclerosing panencephalitis (SSPE) is a chronic, progressive encephalitis linked to measles virus infection.
- Disease prevalence is higher in areas with low measles vaccination rates.
- The exact pathophysiology involves a dysregulated immune response allowing persistent viral infection of neurons.
Purpose of the Study:
- To summarize the current understanding of SSPE's epidemiology, pathophysiology, clinical presentation, diagnosis, and management.
- To highlight the disease's relentless progression and poor prognosis despite treatment efforts.
Main Methods:
- Clinical case reviews and analysis of existing literature on SSPE.
- Diagnostic criteria including clinical presentation, EEG findings, brain imaging, and serological evidence of measles infection.
- Review of treatment trials and outcomes for SSPE.
Main Results:
- SSPE manifests years after initial measles infection, with prominent psychiatric and neurological symptoms.
- Diagnosis relies on a combination of clinical, electrophysiological, imaging, and immunological findings.
- While treatments aim to manage seizures and complications, SSPE shows a grim prognosis, with 95% mortality within 5 years.
Conclusions:
- SSPE remains a devastating complication of measles infection, particularly in under-vaccinated communities.
- Effective prevention through vaccination is crucial.
- Further research into pathophysiology and novel treatments is warranted, though current options offer limited impact on the disease's fatal course.
More Related Videos
08:17Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Brain Abscess l: Introduction
Arboviral Encephalitis
Bacterial Meningitis II: Pathophysiology
Multiple Sclerosis l: Introduction